文献速递免疫规划慢病防控与筛查

VZV IgG血清阴性肾移植候选者接种水痘疫苗后的体液与细胞免疫应答

Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
PubMed 文献 · Vaccine · 2016-11-26

研究纳入VZV IgG不可测的肾移植候选者,间隔6周接种两剂减毒活水痘疫苗,77%(40/52)接种者产生阳性VZV-IgG,82%(9/11)VZV特异性CD4+记忆T细胞增加,CD8+记忆T细胞未增加,无严重疫苗相关不良事件。

要点

  • 间隔6周接种两剂减毒活水痘疫苗后,77%(40/52)接种者VZV-IgG转阳。
  • 82%(9/11)接种者VZV特异性CD4+记忆T细胞增加,CD8+记忆T细胞未增加。
  • 无应答者移植后未发生原发性VZV感染,仅见自行缓解的局部皮肤刺激。

核心结论

  • 减毒活水痘疫苗可在VZV血清阴性潜在肾移植候选者中诱生阳性VZV-IgG水平和VZV特异性记忆T细胞。

研究设计与样本

  • VZV IgG不可测的肾移植候选者间隔6周接种两剂减毒活水痘疫苗,接种后随访VZV IgG至2年,移植前及移植后检测VZV特异性T细胞反应。

主要发现

  • 77%(40/52)的接种者接种后达到阳性VZV-IgG水平(应答者)。
  • 82%(9/11)的接种者VZV特异性CD4+记忆T细胞(包括中央记忆和效应记忆细胞)增加。
  • VZV特异性CD8+记忆T细胞百分比未增加。
  • 无应答者移植后均未发生原发性VZV感染。
  • 未报告严重疫苗相关不良事件,仅见自行缓解的局部皮肤刺激。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In immunocompromised patients, primary infection with VZV may have a disastrous clinical course. Vaccination of VZV-seronegative patients on the waiting list for renal transplantation may prevent severe disease. However, the immunologic response of end-stage renal disease patients to peptide vaccines is far from optimal. Our question was whether end-stage renal disease patients with undetectable VZV-IgG levels were able to mount an adequate humoral and cellular response to a live attenuated varicella vaccine. METHODS: Kidney transplant candidates with undetectable VZV levels were vaccinated twice with a live attenuated varicella vaccine at an interval of 6weeks. VZV IgG levels were analysed till 2years after vaccination. The VZV-specific T-cell reactivity was determined prior to vaccination and after transplantation. RESULTS: Seventy-seven percent (40/52) of the vaccinees reached positive VZV-IgG levels after vaccination (responders). Eighty-two percent (9/11) showed an increase in VZV-specific CD4+ memory T-cells (both central and effector memory cells). The percentage VZV-specific CD8+ memory T-cells did not increase. None of the non-responders suffered from primary VZV after transplantation. No severe vaccine-related adverse events were reported, only spontaneously resolving local skin irritation. CONCLUSION: The live attenuated varicella vaccine evokes positive VZV IgG-levels and VZV-specific memory T-cells in VZV-seronegative potential kidney transplant candidates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kho MM, Zuijderwijk JM, van der Eijk AA, et al. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates. Vaccine. 2016. PMID: 27899225. doi:10.1016/j.vaccine.2016.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。